Tag: Sciences

BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate

 BOC Sciences, a leading CRO in the USA, unveils its comprehensive capabilities for custom peptide drug conjugate from project design to commercial production. With its well-established conjugation platform, BOC Sciences supports pharmaceutical and biotechnology clients at the forefront of drug conjugation. Peptide-drug conjugates (PDCs) are mainly used in anti-cancer therapy, which integrates the advantages of small molecular weight, high tumor penetration, low immunogenicity, large-scale synthesis using solid phase synthesis, low production cost, relatively good pharmacokinetics, and so on. Peptides selected for PDCs can specifically target protein receptors overexpressed in tumor tissue and have strong binding affinity for the target site ... Read more

BOC Sciences Commitment at BIO 2022: From Concept to GMP Production

 BIO International Convention united over 15,000 researchers and top-tier biotech leaders this year to intensively expand their partnerships during the four-day meeting. As a prominent contributor to the pharma industry, BOC Sciences is certified as an eligible exhibitor and allocated booth 1441. The preparation period of BOC Sciences for the BIO conference spans out the first half of 2022, which turns out to be worthwhile since its booth 1441 became a busy spot with many visitors coming to inquire about commercial microbial manufacturing services. The key expertise showcased this year is fermentation for APIs & bioactive metabolites, preclinical CRO services, ... Read more

BOC Sciences Officially Releases the Final Invitation to Renowned Pharma Conferences in May

 BOC Sciences has been preparing for the two exhibitions for a long period, with the hope that all the visiting guests can have every question solved and every need satisfied. Earlier this year, BOC Sciences released its products, services, and expertise to be showcased in May, which aroused great interest of academia and the pharma industry. Among all the exhibits, its mRNA synthesis service becomes the center of attention since the urgent COVID-19 vaccine R & D requires much assistance from it. BOC Sciences is featured with a complete set of custom mRNAs at laboratory and GMP grade. Plus, it ... Read more

New Amsterdam Sciences Announces Pre-IND Stage 2 Submission with FDA Coronavirus Treatment Velocity Program for NAS150 Targeting the Omicron Alternative and all variations of SARS-CoV-2

  New Amsterdam Sciences, an independently held bioscience business, reveals the filing of the Company’s freshly supplied products and information with the FDA’s Coronavirus Treatment Acceleration Program under a pre-Investigation New Drug Phase 2 submission. This submission is an action to a current reaction from the FDA with demands connecting to a previous submission simply weeks prior. The FDA submission is for the development of the Company’s healing representative prospect that has antiviral possibility presently being assessed and validated; NAS150 for the treatment of COVID-19 which is brought on by the SARS-CoV-2 infection and its variations. The Company is likewise ... Read more

BOC Sciences Improves Its Fermentation CDMO Platform for Microbial Drug Development

 BOC Sciences, a provider of CDMO services for the development of microbial drugs, recently announced that it has improved its fermentation CDMO platform to provide a comprehensive one-stop industrial fermentation CDMO service. In the field of biotechnology, fermentation refers to any process in which microbes multiply rapidly to produce a variety of valuable compounds. Bacteria (such as E. coli, the most commonly used microorganism in microbial fermentation), algae, fungus, and actinomycetes are among the microorganisms utilized in biotechnological fermentation and enzyme synthesis. BOC Sciences provides seamless one-stop process development services from concept to commercialization, which can help clients promote their ... Read more